Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: A multi-methodological approach
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 98 (11) , 4216-4228
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletizationInternational Journal of Pharmaceutics, 2007
- Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer–surfactant combinations using solubility parameters and testing the processabilityInternational Journal of Pharmaceutics, 2007
- Preparation of a solid dispersion of felodipine using a solvent wetting methodEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Characterization of solid dispersions of rofecoxib using differential scanning calorimeterJournal of Thermal Analysis and Calorimetry, 2005
- Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying methodInternational Journal of Pharmaceutics, 2005
- Solid-state characterization of nifedipine solid dispersionsInternational Journal of Pharmaceutics, 2002
- The mechanisms of drug release from solid dispersions in water-soluble polymersInternational Journal of Pharmaceutics, 2002
- The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessmentInternational Journal of Pharmaceutics, 2000
- Improving drug solubility for oral delivery using solid dispersionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000